352 related articles for article (PubMed ID: 29135289)
21. [Ten questions about transthyretin amyloidosis].
Giovannetti A; Accietto A; Massa P; Leone O; Guaraldi P; Saturi G; Caponetti AG; Sguazzotti M; Ponziani A; Gagliardi C; Galiè N; Cortelli P; Longhi S; Biagini E
G Ital Cardiol (Rome); 2022 Sep; 23(9):676-685. PubMed ID: 36039718
[TBL] [Abstract][Full Text] [Related]
22. Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac response.
Grogan M; Dispenzieri A; Gertz MA
Heart; 2017 Jul; 103(14):1065-1072. PubMed ID: 28456755
[TBL] [Abstract][Full Text] [Related]
23. [The Changing Appearance of Cardiac Amyloidosis].
Mahrholdt H; Klingel K; Sechtem U
Dtsch Med Wochenschr; 2018 Sep; 143(18):1335-1343. PubMed ID: 30199915
[TBL] [Abstract][Full Text] [Related]
24. Diagnosis and Treatment of Transthyretin Cardiac Amyloidosis. Progress and Hope.
González-López E; López-Sainz Á; Garcia-Pavia P
Rev Esp Cardiol (Engl Ed); 2017 Nov; 70(11):991-1004. PubMed ID: 28870641
[TBL] [Abstract][Full Text] [Related]
25. Cardiac amyloidosis-interdisciplinary approach to diagnosis and therapy.
Hänselmann A; Berliner D; Bauersachs J; Bavendiek U
Herz; 2022 Aug; 47(4):324-331. PubMed ID: 35674775
[TBL] [Abstract][Full Text] [Related]
26. Amyloid diseases of the heart: current and future therapies.
Dubrey SW; Comenzo RL
QJM; 2012 Jul; 105(7):617-31. PubMed ID: 22223674
[TBL] [Abstract][Full Text] [Related]
27. Diagnosis and Treatment of Cardiac Amyloidosis Related to Plasma Cell Dyscrasias.
Alexander KM; Evangelisti A; Witteles RM
Cardiol Clin; 2019 Nov; 37(4):487-495. PubMed ID: 31587789
[TBL] [Abstract][Full Text] [Related]
28. Novel strategies for the diagnosis and treatment of cardiac amyloidosis.
Palladini G; Milani P; Merlini G
Expert Rev Cardiovasc Ther; 2015 Nov; 13(11):1195-211. PubMed ID: 26496239
[TBL] [Abstract][Full Text] [Related]
29. [Cardiac amyloidosis].
Hoyer C; Angermann CE; Knop S; Ertl G; Störk S
Med Klin (Munich); 2008 Mar; 103(3):153-60. PubMed ID: 18344065
[TBL] [Abstract][Full Text] [Related]
30. Cardiac amyloidosis: from clinical suspicion to morphological diagnosis.
Flodrova P; Flodr P; Pika T; Vymetal J; Holub D; Dzubak P; Hajduch M; Scudla V
Pathology; 2018 Apr; 50(3):261-268. PubMed ID: 29448998
[TBL] [Abstract][Full Text] [Related]
31. [Cardiac amyloidosis: How to recognize them and manage them?].
Bodez D; Galat A; Guellich A; Deux JF; Rosso J; Le Bras F; Funalot B; Fanen P; Benhaiem N; Planté-Bordeneuve V; Dubois-Randé JL; Lellouche N; Guendouz S; Molinier-Frenkel V; Mohty D; Damy T
Presse Med; 2016 Oct; 45(10):845-855. PubMed ID: 27492996
[TBL] [Abstract][Full Text] [Related]
32. Amyloid cardiomyopathy.
Karafiatova L; Pika T
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Jun; 161(2):117-127. PubMed ID: 28145535
[TBL] [Abstract][Full Text] [Related]
33. Cardiac involvement with amyloidosis: mechanisms of disease, diagnosis and management.
Marcu CB; Niessen HW; Beek AM; Brouwer WP; Robbers LF; Van Rossum AC
Conn Med; 2011; 75(10):581-90. PubMed ID: 22216672
[TBL] [Abstract][Full Text] [Related]
34. Optimization of Serum Immunoglobulin Free Light Chain Analysis for Subclassification of Cardiac Amyloidosis.
Halushka MK; Eng G; Collins AB; Judge DP; Semigran MJ; Stone JR
J Cardiovasc Transl Res; 2015 Jun; 8(4):264-8. PubMed ID: 25925232
[TBL] [Abstract][Full Text] [Related]
35. Canadian Cardiovascular Society/Canadian Heart Failure Society Joint Position Statement on the Evaluation and Management of Patients With Cardiac Amyloidosis.
Fine NM; Davis MK; Anderson K; Delgado DH; Giraldeau G; Kitchlu A; Massie R; Narayan J; Swiggum E; Venner CP; Ducharme A; Galant NJ; Hahn C; Howlett JG; Mielniczuk L; Parent MC; Reece D; Royal V; Toma M; Virani SA; Zieroth S
Can J Cardiol; 2020 Mar; 36(3):322-334. PubMed ID: 32145862
[TBL] [Abstract][Full Text] [Related]
36. Extracellular Volume Detects Amyloidotic Cardiomyopathy and Correlates With Neurological Impairment in Transthyretin-familial Amyloidosis.
Gallego-Delgado M; González-López E; Muñoz-Beamud F; Buades J; Galán L; Muñoz-Blanco JL; Sánchez-González J; Ibáñez B; Mirelis JG; García-Pavía P
Rev Esp Cardiol (Engl Ed); 2016 Oct; 69(10):923-930. PubMed ID: 27291669
[TBL] [Abstract][Full Text] [Related]
37. Advances in pharmacotherapy for cardiac amyloidosis.
Spoladore R; Falasconi G; Marcatti M; Di Maio S; Fiore G; Slavich M; Margonato A; Turco A; Fragasso G
Expert Opin Pharmacother; 2021 Mar; 22(4):469-481. PubMed ID: 33043721
[TBL] [Abstract][Full Text] [Related]
38. Amyloid transthyretin cardiac amyloidosis with different manifestations, test findings and types.
Budweg J; Al-Ani M; Assaf Y; Parker A; Aranda J
BMJ Case Rep; 2023 Apr; 16(4):. PubMed ID: 37080632
[TBL] [Abstract][Full Text] [Related]
39. Management of Cardiac Amyloidosis: Do's and Don'ts.
Alexander KM; Witteles RM
Can J Cardiol; 2020 Mar; 36(3):444-446. PubMed ID: 32033795
[TBL] [Abstract][Full Text] [Related]
40. Cardiac amyloidosis: where are we today?
Patel KS; Hawkins PN
J Intern Med; 2015 Aug; 278(2):126-44. PubMed ID: 26077367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
